KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Cardlytics (CDLX) Shares Outstanding (2016 - 2026)

Cardlytics filings provide 11 years of Shares Outstanding readings, the most recent being $55.1 million for Q1 2026.

  • Quarterly Shares Outstanding rose 5.55% to $55.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $55.1 million through Mar 2026, up 5.55% year-over-year, with the annual reading at $54.5 million for FY2025, 6.35% up from the prior year.
  • Shares Outstanding hit $55.1 million in Q1 2026 for Cardlytics, up from $54.5 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $55.1 million in Q1 2026 and bottomed at $32.9 million in Q2 2022.
  • Average Shares Outstanding over 5 years is $44.1 million, with a median of $48.2 million recorded in 2024.
  • The largest annual shift saw Shares Outstanding decreased 0.43% in 2023 before it surged 43.18% in 2024.
  • Cardlytics' Shares Outstanding stood at $33.5 million in 2022, then increased by 18.67% to $39.7 million in 2023, then rose by 29.02% to $51.3 million in 2024, then rose by 6.35% to $54.5 million in 2025, then grew by 1.02% to $55.1 million in 2026.
  • Per Business Quant, the three most recent readings for CDLX's Shares Outstanding are $55.1 million (Q1 2026), $54.5 million (Q4 2025), and $51.3 million (Q3 2025).